In response to the COVID-19 pandemic, one of the largest global medical technology companies has launched a new rapid detection test with help from its research and development team right here in Maryland.
BD – also known as Becton, Dickinson and Company – has had a presence in Maryland since the 1950s, and currently has its Integrated Diagnostic Solutions business headquartered in Sparks.
The company’s new point-of-care diagnostic test can detect the SARS-CoV-2 virus using its BD Veritor™ Plus System, a machine that is already being used for other diagnostics in more than 28,000 laboratories and hospitals worldwide.
According to a recent release, BD anticipates producing up to 10 million tests this summer. And, with a new $24 million investment from the U.S. Department of Defense and U.S. Department of Health and Human Services, the company could produce more than 12 million kits by February 2021.
